Literature DB >> 24515568

Value of preoperative inflammation-based prognostic scores in predicting overall survival and disease-free survival in patients with gastric cancer.

Paolo Aurello1, Simone Maria Tierno, Giammauro Berardi, Federico Tomassini, Paolo Magistri, Francesco D'Angelo, Giovanni Ramacciato.   

Abstract

BACKGROUND: This study was designed to identify which are the best preoperative inflammation-based prognostic scores in terms of overall survival (OS) and disease-free survival (DFS) in patients with gastric cancer.
METHODS: Between January 2004 and January 2013, 102 consecutive patients underwent resection for gastric cancer at S. Andrea Hospital, "La Sapienza", University of Rome. Their records were retrospectively reviewed.
RESULTS: After a median follow up of 40.8 months (8-107 months), patients' 1-, 3-, and 5-year OS rates were 88, 72, and 59 %, respectively. After R0 resection, the 1-, 3-, and 5-year DFS rates were 93, 74, and 56 %, respectively. A multivariate analysis of the significant variables showed that only the modified Glasgow prognostic scores (p < 0.001) and PI (p < 0.001) were independently associated with OS. Regarding DFS, multivariate analysis of the significant variables showed that the modified Glasgow prognostic score (p = 0.002) and prognostic index (p < 0.001) were independently associated with DFS.
CONCLUSIONS: The results of this study show that modified Glasgow prognostic score and prognostic index are independent predictors of OS and DFS in patients with gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24515568     DOI: 10.1245/s10434-014-3533-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  19 in total

1.  Modified glasgow prognostic score as a prognostic factor in gastriccancer patients: a systematic review and meta-analysis.

Authors:  Xinwu Zhang; Xi Chen; Tao Wu; Yan Zhang; Kun Yan; Xiaoli Sun
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  Outcomes in patients with pancreatic cancer as a secondary malignancy: a retrospective single-institution study.

Authors:  Sojun Hoshimoto; Shoichi Hishinuma; Hirofumi Shirakawa; Moriaki Tomikawa; Iwao Ozawa; Yoshiro Ogata
Journal:  Langenbecks Arch Surg       Date:  2019-11-25       Impact factor: 3.445

3.  Comparison of Glasgow prognostic score and prognostic index in patients with advanced non-small cell lung cancer.

Authors:  Ai-Gui Jiang; Hong-Lin Chen; Hui-Yu Lu
Journal:  J Cancer Res Clin Oncol       Date:  2014-09-26       Impact factor: 4.553

4.  Prognostic Value and Association of Sarcopenia and Systemic Inflammation for Patients with Gastric Cancer Following Radical Gastrectomy.

Authors:  Jian-Xian Lin; Jun-Peng Lin; Jian-Wei Xie; Jia-Bin Wang; Jun Lu; Qi-Yue Chen; Long-Long Cao; Mi Lin; Ruhong Tu; Chao-Hui Zheng; Chang-Ming Huang; Ping Li
Journal:  Oncologist       Date:  2019-03-25

5.  Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric Adenocarcinoma.

Authors:  Sam C Wang; Joanne F Chou; Vivian E Strong; Murray F Brennan; Marinela Capanu; Daniel G Coit
Journal:  Ann Surg       Date:  2016-02       Impact factor: 12.969

6.  Prognostic value of the Glasgow Prognostic Score in renal cell carcinoma: a meta-analysis.

Authors:  Sung Ryul Shim; Se Joong Kim; Sun Il Kim; Dae Sung Cho
Journal:  World J Urol       Date:  2016-09-24       Impact factor: 4.226

7.  Copper chelation by trientine dihydrochloride inhibits liver RFA-induced inflammatory responses in vivo.

Authors:  Ji-Ming Yin; Li-Bo Sun; Jia-Sheng Zheng; Xin-Xin Wang; De-Xi Chen; Ning Li
Journal:  Inflamm Res       Date:  2016-09-09       Impact factor: 4.575

8.  Prognostic significance of neutrophil lymphocyte ratio in patients with gastric cancer: a meta-analysis.

Authors:  Xi Zhang; Wei Zhang; Li-jin Feng
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

9.  Association between pretreatment Glasgow prognostic score and gastric cancer survival and clinicopathological features: a meta-analysis.

Authors:  Chun-Xiao Zhang; Shu-Yi Wang; Shuang-Qian Chen; Shuai-Long Yang; Lu Wan; Bin Xiong
Journal:  Onco Targets Ther       Date:  2016-06-27       Impact factor: 4.147

Review 10.  Can the Neutrophil to Lymphocyte Ratio Be Used to Determine Gastric Cancer Treatment Outcomes? A Systematic Review and Meta-Analysis.

Authors:  Jingxu Sun; Xiaowan Chen; Peng Gao; Yongxi Song; Xuanzhang Huang; Yuchong Yang; Junhua Zhao; Bin Ma; Xinghua Gao; Zhenning Wang
Journal:  Dis Markers       Date:  2016-01-26       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.